✦ LIBER ✦

Immunoadsorption as a rescue therapy in systemic lupus erythematosus: considerations on safety and efficacy

✍ Scribed by Georg H. Stummvoll; Martin Aringer; Martin Jansen; Josef S. Smolen; Kurt Derfler; Winfried B. Graninger

Publisher: Springer Vienna
Year: 2004
Tongue: English
Weight: 121 KB
Volume: 116
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-004-0232-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of rituximab in mode

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

✍ Joan T. Merrill; C. Michael Neuwelt; Daniel J. Wallace; Joseph C. Shanahan; Kevi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

## Abstract ## Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE Evaluation of Rituximab (EXPLORER) trial tested the efficacy and safety of rituximab versus placebo in p

B cell depletion therapy in systemic lup

B cell depletion therapy in systemic lupus erythematosus: Effect on autoantibody and antimicrobial antibody profiles

✍ G. Cambridge; M. J. Leandro; M. Teodorescu; J. Manson; A. Rahman; D. A. Isenberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

## Abstract ## Objective Autoantibody production in patients with systemic lupus erythematosus (SLE) is associated with abnormalities of B cell function and phenotype. Clinical responses to B cell depletion therapy (BCDT), based on rituximab, are encouraging. Therefore, we undertook this study to

Tocilizumab in systemic lupus erythemato

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

✍ Gabor G. Illei; Yuko Shirota; Cheryl H. Yarboro; Jimmy Daruwalla; Edward Tackey; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Granulocyte colony-stimulating factor th

Granulocyte colony-stimulating factor therapy resulting in a flare of systemic lupus erythematosus: comment on the article by Yang and Hamilton

✍ Jacques-Eric Gottenberg; Sophie Roux; Frédéric Desmoulins; Didier Clerc; Xavier 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Thrombocytopenia as a prognostic factor

Thrombocytopenia as a prognostic factor in Hispanic patients with systemic lupus erythematosus: Comment on the article by Fernández et al

✍ Cristina Drenkard; Antonio R. Villa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Laboratory tests as predictors of diseas

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: Comment on the article by Esdaile et al

✍ Ruud J. T. Smeenk; Lucien A. Aarden; Tom J. G. Swaak; John M. Esdaile; Michal Ab 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 2 views